Endocrinology

Those who have lost a significant amount of weight are often left with sagging skin, and exercise is not the solution to that problem.

Study results indicate androgen-deprivation therapy (ADT) does not extend the lives of men with early-stage prostate cancer.

A recent article examines the factors that influence a clinician's decision to continue a statin-intolerant patient on statin therapy when the benefits potentially outweigh the risks.

Since roughly 70-80% of indeterminate thyroid nodules are diagnosed as benign from histologic follow-up of fine-needle aspiration cytology, researchers have conducted numerous studies to identify the clinical risk factors that predict malignancy.

While rhabdomyolysis has been recognized as a consequence of crush injuries since the late 1800s, the most significant step toward finding the condition's causes, mechanisms, and management strategies occurred when physicians who treated crush injuries from the 1941 London Blitz identified a link between rhabdomyolysis and renal impairment.

Since many patients have insulin resistance, prescribing insulin therapy for diabetes often requires trial and error.

In a recent survey, physicians identified peer-reviewed journal articles, continuing medical education, evidence-based guidelines, and national experts as the most useful sources of information to stay current on therapeutic advances.

Although the healthcare community's understanding of the hypothalamic-pituitary-adrenal axis under stress is fairly good, one point has baffled researchers.

When patients with primary hypothyroidism report weight gain, most clinicians understandably believe that initiating appropriate thyroid hormone treatment will reverse the symptom.

Since removing the abnormal glands through parathyroidectomy (PTx) is the sole curative intervention for primary hyperparathyroidism (PHPT), a team of researchers from the Section of Endocrine Surgery at the UCLA David Geffen School of Medicine in Los Angeles recently tracked trends in the frequency and quality of PTx.

Researchers in Australia have released the results of a study showing that dropping testosterone levels in older men could potentially put them at risk when taking care of themselves in their later years.

As the bioactive fatty acids in milk have been tentatively linked to anti-inflammatory and improved metabolic effects, its calcium, magnesium, phosphorus, and potassium content may lower blood pressure and alleviate cardiometabolic syndrome.

Since many patients with night eating syndrome (NES) believe they will not fall back asleep until they ingest a full meal, it's no surprise that NES is associated with obesity and metabolic abnormalities.

Researchers analyzed records from more than 25,000 Medicare beneficiaries and found no evidence that testosterone replacement therapy increases the risk of heart attack among older men.

An endocrinologist from the University Hospital Basel in Switzerland discusses the role of inflammation in the pathogenesis of type 2 diabetes, outlining the reasons why clinicians should target inflammation when treating diabetics.

When patients with diabetes or metabolic syndrome experience acute cardiac events, the subject of stents often arises.

The patients who are most likely to develop a hospital-acquired condition after bariatric surgery are precisely those who stand to benefit the most from undergoing the procedure.

The US Food and Drug Administration recently announced it will require the makers of testosterone replacement therapies to add general warnings about venous blood clots to product labels.

Although hospitals routinely implement peer review processes to ensure that physicians are meeting the prevailing standards of care, the procedure has been associated with controversy.

Study results show that obese patients with psoriatic arthritis who were treated with tumor necrosis factor-alpha blockers who also lost at least 5 percent of their bodyweight from baseline were much more likely to achieve minimal disease activity.

Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.

Early research at Columbia University could provide a breakthrough in the treatment of diabetes.

The Food and Drug Administration (FDA) has announced the approval of a new medication aimed at helping the nearly 26 million people in the country with diabetes.

Patients with osteoporosis got some good news at a recent conference when the results of a study showed that taking the drug denosumab can help increase bone density and keep their rate of fractures at a low level.

A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.

Obese and overweight patients who were treated with the drug liraglutide experienced significant weight loss and were less likely to develop type 2 diabetes than patients who received placebo.

An experimental, first-in-class drug that affects the gut microbiota has been shown to improve glucose tolerance and insulin sensitivity in adults with prediabetes.

A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man's testosterone levels as helping determine sleep quality.

This marks the first testosterone nasal gel for replacement therapy in adult males approved by the FDA for conditions associated with a deficiency or absence of endogenous testosterone.